Brief: Irlab Q2 Operating Loss At SEK 27.1 Million

IRLAB Therapeutics AB

24/08/2022 06:08

Aug 24 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * NET SALES RECORDED IN Q2 SEK 23.4 MILLION VERSUS SEK 0
MILLION
YEAR AGO
    * Q2 OPERATING LOSS SEK 27.1 MILLION VERSUS LOSS SEK 26.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFNbgwTSl 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))